AiTA's Closed-Loop

October-December 2024   

AiTA is developing a hybrid closed-loop insulin delivery system that combines glucose sensing and insulin pumping into a single wearable for patients with type 1 diabetes. To accelerate FDA clearance for the mobile companion app, AiTA chose to build the app on top of the open-source Tidepool Loop platform—requiring careful UX adaptation, safety-first decision-making, and a phased approach to onboarding and device control.